Pharmaceutical Portfolio Management in Russia

Announcement: Adam Smith Institute Forum "Pharmaceutical Portfolio Management in Russia"
Farmvestnik

The Adam Smith Institute Forum "Pharmaceutical Portfolio Management in Russia: Creating Successful Product Strategies and Alliances" (PPPM – Russia) will be held on March 2-3, 2011 in Basel, Switzerland.

Key Forum sessions:

• Discussion of industry leaders. The discussion will be attended by CEOs and Regional Managers of such companies as Novartis, GlaxoSmithKline, F. Hoffmann La Roche, Nycomed and Dr. Reddy's, who will share their vision of possible scenarios for the development of the sector, as well as analyze the most important elements of any successful growth strategy of the company in rapidly developing markets.
• In–depth session - "Search for opportunities and creation of successful alliances in Russia". Participants: Alain Genre-Grandpierre, Director of Commercial Operations, Central, Eastern and Southern Europe, Biogen Idec International; Hadi Moufarray, Vice President of Sales, EMEA, Medical Diagnostics, GE Healthcare; Konstantin Bakaykin, Director of Business Development, Nycomed; Ralph Weintrub, President, INVAR Group of Companies; Paolo de Angeli, General Manager of the International Division, Chiesi, Italy.
• Analytical review – "Comparative analysis of the European and Russian pharmaceutical markets". Participants: David Kambell, Head of Direction, IMS Health; Maria Denisova, Chief Operating Officer, IMS-Health, Russia; Oleg Feldman, General Manager, Comcon-Pharma, Russia.
• A session of short presentations consisting of a series of five-minute speeches by both Russian and international companies representing their interest in entering into partnership alliances, the continuation of the session will be one-on-one meetings.
• A special focus session dedicated to strategic, financial, marketing and commercial aspects of product portfolio management in the region.
• Work-shop – "Evaluation of existing business models to achieve a competitive advantage in the generic market". This 3-hour hands-on work-shop will be conducted jointly by Malcolm Ross, President of Generapharm Consultancy, Switzerland and Veniamin Munblit, Director of the Department of Analytics and Consulting, Comcon-Pharma, Russia.

More information about the forum is available on the Adam Smith Conferences website

Portal "Eternal youth" http://vechnayamolodost.ru
02.02.2011